CODX(Delisted)
Co-diagnostics·NASDAQ
--
--(--)
CODX fundamentals
Co-diagnostics (CODX) released its earnings on Aug 14, 2019: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 14, 2019
EPS
Revenue
Revenue & Expenses
CODX has released its 2025 Q3 earnings report, with revenue of 145.38K, reflecting a YoY change of -77.32%, and net profit of -5.89M, showing a YoY change of 39.29%. The Sankey diagram below clearly presents CODX's revenue sources and cost distribution.
Key Indicators
Co-diagnostics (CODX) key financial stats and ratios, covering profitability, financial health, and leverage.
Co-diagnostics (CODX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Co-diagnostics (CODX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Co-diagnostics (CODX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Co-diagnostics (CODX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Co-diagnostics (CODX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
